| 1 |
Patient presents with fever and sore throat. |
F |
23 |
38.4 |
Negative |
<10 |
A clinically significant change in symptoms and CRP (within normal) was observed. |
| 2 |
Patient presents with fever, dry cough, rhinitis symptoms, shortness of breath. |
M |
61 |
within normal 0-10 |
Positive |
Not performed |
The shortness of breath disappeared after 3rd day. Fever disappeared after two days of the therapy. |
| 3 |
Patient presents with fever and general weakness without any infect focus or flu-like symptoms. |
M |
73 |
123.4 |
Negative |
40 |
Fever disappeared, and CRP reduced lower than 40 mg/L after 3 days of treatment. |
| 4 |
Patient presents with dry cough, fever, and headache. |
F |
37 |
51.7 |
Negative |
Not performed |
The feedback came positive as it has been received by telephone. The follow appointment was cancelled as the patient gained her health back and had no symptoms on day 5 of the therapy. |
| 5 |
Patient with a history of hypertension and hyperlipidemia who presented with fever, dry cough, malaise, and general weakness. |
F |
77 |
16.6 |
Positive |
<10 |
The patient went to the hospital for supportive treatment and was discharged on the next day as there was no indication for hospitalization. Her main symptoms disappeared after 5 days of NS therapy. COVID PCR was repeated after 12 days of having the therapy and showed a negative PCR test. |
| 6 |
A 77-year-old patient with a history of hyperlipidemia and hypertension, obesity and atrial fibrillation who presented with shortness of breath, fever and dry cough. |
F |
77 |
80 |
Negative |
20.2 |
Significant improvement of her general health. NS was taken for 2.5 days. CRP was followed to be 20.2 mg/L. |
| 7 |
Dry cough with general weakness and abdominal cramps and diarrhea. |
M |
23 |
66.9 |
Negative |
22.3 |
Significant clinical improvement within 3 days. CRP reduced to 22.3 mg/L. |
| 8 |
Patient presented to us with high grade fever without localizing signs or symptoms or any infect focus. |
M |
38 |
38.1 |
Negative |
10.5 |
Fever disappeared after 1-day of treatment. CRP performed after 3 days of the therapy it came down to 10.5mg/L. |
| 9 |
Patient with chief complaints of sore throat with fever. Her daughter was diagnosed with COVID-19. |
F |
56 |
Not performed |
Positive |
Not performed |
Clinical symptoms rapidly improved after 3 days. |
| 10 |
Patient presented to us with fever, dry cough, running nose, and general weakness. |
M |
39 |
73 |
Negative |
5.7 |
Clinical symptoms rapidly improved after 3 days CRP reduced after 6 days of treatment 5.7 mg/L. |
| 11 |
Patient was diagnosed with COVID-19. She consulted us by telephone after 10 days of the diagnosis as her general health worsened with having pesky cough accompanied by chest pain, shortness of breath, and fever. Treatment with NS was given at this time. |
F |
52 |
Not performed |
Positive |
Not performed |
Clinical symptoms rapidly improved within 3 days. No shortness of breath, significantly reducing cough severity and frequency. |
| 12 |
Patient was hospitalized in the ICU due to severity of his COVID- 19 symptoms and has received supportive therapy. He consulted us by telephone after being discharged from the hospital due to general weakness, dry cough accompanied by chest pain and shortness of breath. |
M |
50 |
24 |
Positive |
<10 |
After intake of NS therapy, the shortness of breath was significantly reduced within 3 days and patient developed a significant improvement of his general health. SARS-CoV-2 PCR obtained on day 7 of his NS therapy and has shown a negative PCR test. CRP found to be within normal level. Chest X-ray performed after 8 weeks of the therapy and showed normal findings. |
| 13 |
Patient presented to us with fever, general weakness, sweating. |
F |
68 |
127.2 |
Negative |
81.3 |
Significant improvement of her general health. Fever disappeared in the first 2days of the therapy. CRP dropped to 81.3 mg/L after two days of NS therapy. |
| 14 |
Patient presented to us with fever, dry cough, and general weakness. |
M |
51 |
84.5 |
Negative |
40.5 |
The symptoms were significantly reduced after two days. CRP decreased to 40.5 mg/L during the second of the therapy. |
| 15 |
Patient presented to us with fever, nasal congestion and dry cough. |
M |
48 |
45.6 |
Negative |
5.2 |
The symptoms were relieved completely after 4 days. CRP dropped to 5.2 mg/L after 4 days of treatment. |
| 16 |
Patient presented with fever, general weakness and headache. |
M |
27 |
114.4 |
Negative |
36.2 |
The fever disappeared on the second day of treatment the patient gained his health back after two days. CRP decreased to 36.2 mg/L after 3 days of the therapy. |
| 17 |
Patient presented with dry cough, fever, nasal congestion and sneezing. |
F |
56 |
58.5 |
Negative |
- |
According to the patient the symptoms were significantly disappeared after 4 days of treatment. CRP was not measured. |
| 18 |
Patient presented to us with sweating, mild increased in her temperature. Flu symptoms were denied. No infect focus was determined. |
F |
72 |
32.6 |
Negative |
14.6 |
Symptoms were relieved after 3 days. CRP reduced to 14.6 mg/L on the 3rd day of treatment. |
| 19 |
Patient presented to us with dry cough and mild shortness of breath. |
M |
72 |
Not performed |
Positive |
Not performed |
Clinical symptoms rapidly improved within 3 days. SARS-CoV-2 PCR was obtained on day 16 of his NS therapy and was negative. |
| 20 |
Patient with productive cough, fever, and malaise. |
M |
41 |
47.6 |
Negative |
9.8 |
Clinical symptoms rapidly improved within 3 days. CRP reduced to 9.8 mg/L on day 3 of his NS therapy. |
| 21 |
Patient presented with fever, cough, and headache. |
F |
57 |
70 |
Positive |
40 |
Clinical symptoms rapidly improved within 3 days. CRP reduced 40 mg/L on day 3 of her NS therapy. |
| 22 |
Patient with known psoriasis presented with fever, headache, malaise, dry cough with general weakness. |
M |
48 |
82.7 |
Negative |
15.3 |
Clinical symptoms rapidly improved within 3 days. CRP reduced to 15.3 mg/L on day 4 of his NS therapy. |
| 23 |
Patient consulted us by telephone due to increase of her respiratory symptoms. She reports that the cough has increased suddenly, and she gained general weakness. Now she is isolated because she was tested positively with COVID- 19. No fever, no chills. Her past history shows only that she was treated due to depression. |
F |
47 |
Not performed |
Positive |
Not performed |
A telephone consultation followed after two days. The clinical symptoms rapidly improved. |
| 24 |
Patient presents with acute respiratory symptoms, malaise and fever. |
F |
16 |
37.5 |
Negative |
21.2
|
Clinical symptoms rapidly improved within 3 days. CRP reduced to 21.2 mg/L on day 2 of her NS therapy. |
| 25 |
Patient presented with cough, malaise, fatigue, subfebrile temperature. |
F |
62 |
Not performed |
Positive |
Not performed |
Clinical symptoms rapidly improved on day 3 of the therapy. |
| 26 |
Patient presents with fever and cough. His wife was tested positive one week ago. |
M |
76 |
Not performed |
Positive |
Not performed |
Clinical symptoms rapidly improved on day 3 of the therapy. |
| 27 |
Patient presents with fever, cough, malaise and muscle pain. |
F |
75 |
Not performed |
Positive |
Not performed |
Clinical symptoms rapidly improved on day 3 of the therapy. |
| 28 |
Patient presents with cough and fever. |
F |
48 |
Not performed |
Positive |
Not performed |
Clinical symptoms rapidly improved on day 4 of the therapy. Fever disappeared on day 2 of the therapy. |
| 29 |
Patient presents with cough, sore throat, fever and fatigue. One week ago, he had contact with his colleagues who were tested positive for COVID-19. The history is significant for hypertension. |
M |
59 |
Not performed |
Positive |
Not performed |
Clinical symptoms rapidly improved on day 3 of the therapy. The fatigue was significantly reduced but did not disappear. |
| 30 |
Patient with history of hypertension and atrial fibrillation presents with cough, malaise and fatigue. She attended a musical festival where a member tested to carry COVID-19. |
F |
73 |
Not performed |
Positive |
Not performed |
Clinical symptoms rapidly improved on day 3 of the therapy. The cough was significantly reduced. |
| 31 |
Patient presents with fever and general weakness. The medical history is significant for dyslipidemia. His wife tested positive for COVID-19 5 days before his symptoms started. |
M |
61 |
Not performed |
Positive |
Not performed |
Clinical symptoms rapidly improved on day 3 of the therapy. The fever resolved on day 2 of the therapy. |
| 32 |
Patient presents with headache, fatigue, sore throat, and cough. She had contact with her relative who tested to carry covid-19. |
F |
33 |
Not performed |
Positive |
Not performed |
Clinical symptoms rapidly disappeared on day 3 of the therapy. |
| 33 |
Patient presents to us with cough and malaise. |
F |
31 |
Not performed |
Positive |
Not performed |
The symptoms disappeared on day 4 of the therapy. |
| 34 |
Patient presents to us with cough, rhinitis, fever, and fatigue. |
M |
56 |
Not performed |
Positive |
Not performed |
Clinical symptoms rapidly improved on day 3 of the therapy. The fever disappeared after one day of the therapy. |
| 35 |
Patient presents with sore throat, cough, shoulder pain, malaise, fatigue. |
M |
47 |
Not performed |
Positive |
Not performed |
Clinical symptoms rapidly improved on day 3 of the therapy. |